ABSTRACT
INTRODUCTION AND OBJECTIVES: Thoracic ultrasound (TUS) has been established as a powerful diagnostic and monitoring tool in the Intensive Care Unit (ICU). However, studies outside the critical care setting are scarce. The aim of this study was to investigate the value of TUS for hospitalized or ambulatory community patients. MATERIALS AND METHODS: This was a retrospective study conducted from 2016 to 2020 in the TUS clinic at Heraklion University Hospital. TUS examination was performed using a standard ultrasound machine (EUB HITACHI 8500), and a high-frequency microconvex probe (5-8 MHz). Patients had been referred by their primary physician to address a range of different questions. The various respiratory system entities were characterised according to internationally established criteria. RESULTS: 762 TUS studies were performed on 526 patients due to underlying malignancy (n = 376), unexplained symptoms/signs (n = 53), pregnancy related issues (n = 42), evaluation of abnormal findings in X-ray (n = 165), recent surgery/trauma (n = 23), recent onset respiratory failure (n = 12), acute respiratory infection (n = 66) and underlying non-malignant disease (n = 25). Pleural effusion was the commonest pathologic entity (n = 610), followed by consolidation (n = 269), diaphragmatic dysfunction/paradox (n = 174) and interstitial syndrome (n = 53). Discrepancies between chest X-ray and ultrasonographic findings were demonstrated in 96 cases. The TUS findings guided invasive therapeutic management in 448 cases and non-invasive management in 43 cases, while follow-up monitoring was decided in 271 cases. CONCLUSIONS: This study showed that TUS can identify the most common respiratory pathologic entities encountered in hospitalized and community ambulatory patients, and is especially useful in guiding the decision making process in a diverse group of patients.
ABSTRACT
AIM: To evaluate the factors affecting radiation exposure using radial access (RA) including technical aspects and clinical characteristics. MATERIALS AND METHODS: Patients (n=6,967) who underwent coronary angiography (CA) with or without percutaneous coronary intervention (PCI), performed via a right or left RA were evaluated retrospectively. Data were evaluated in two different categories: diagnostic CA group and PCI group. The primary end-points of the study were fluoroscopy time (FT), dose-area product (DAP), and air kerma (AK). RESULTS: Male sex and left RA were characterised by increased DAP and AK, in both the CA and PCI groups. In the CA group, body weight, height, body surface area (BSA), left RA, and male sex were independent prognostic factors of increased radiation. In the PCI group, body weight, height, BSA, left RA, male sex, and older age were independent prognostic factors of increased radiation while older age and left RA were independent prognostic factors for increased FT. CONCLUSION: Radial side, gender, and the physical characteristics of the patients were factors that increased radiation exposure in patients undergoing transradial coronary procedures. Therefore, these factors should be taken into account to help minimise radiation exposure for both patients and operators.
Subject(s)
Percutaneous Coronary Intervention , Radiation Exposure , Body Weight , Cardiac Catheterization/adverse effects , Cardiac Catheterization/methods , Coronary Angiography/methods , Femoral Artery , Fluoroscopy/methods , Humans , Male , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/methods , Radial Artery/diagnostic imaging , Radiation Dosage , Retrospective StudiesABSTRACT
BACKGROUND: Use of LMWH in pregnancy is not only limited to VTE management, but it extends, to the management of vascular gestational complications and the optimization of IVF pregnancies despite the lack of concrete scientific evidence. In this context, we conducted the present study aiming to gain insights regarding the use of LMWH during pregnancy and puerperium. We recorded indication for use, diagnostic work-up as well as the safety and efficacy of the treatment, trying to elucidate the clinical practice in our country. METHODS: We analyzed data regarding 818 pregnant women received LMWH during 2010-2015.Our cohort had a median age of 33.9 years and a BMI of 23.6.There were 4 groups: those with a history of VTE [Group-A: 76], those with pregnancy complications [Group-B: 445], those undergoing IVF [Group-C: 132] and those carrying prothrombotic tendency (thrombophilia, family history of VTE, other) [Group-D: 165]. Mean duration of LMWH administration was 8.6 ± 1.5 months. Out of the total number, 440 received LMWH in fixed prophylactic dose, 272 in higher prophylactic-weight adjusted dose and 106 in therapeutic dose. Moreover, 152 women received in addition low-dose acetylsalicylic acid (ASA). 93.8% of pregnancies were single and 6.2% were multiple ones. Live births occurred in 98.7% of pregnancies. RESULTS: Anticoagulation was efficacious and well tolerated. Seventeen VTE events were recorded; 7 of them antepartum and 10 postpartum. No major bleeding events were observed while 13 clinical relevant non-major bleeding events were recorded. Regarding gestational vascular complications, 28 IUGR events were recorded, as well as 48 cases of preterm labor of which 12 were concomitant with IUGR (25%). Six early pregnancy losses were recorded; there were 3 fetal deaths and 3 cases of pre-eclampsia/eclampsia. CONCLUSIONS: LMWHs are used extensively during pregnancy and puerperium in Greece for VTE treatment and prophylaxis and for a variety of other indications as well. Although the drug has been shown to be both safe and efficacious, its use for some indications has no proven scientific evidence. In order to clearly define the role of LMWHs in pregnancy, beyond thromboprophylaxis, large prospective studies are required, which could be based on the conclusions of this study.
ABSTRACT
OBJECTIVE: To assess if the amount of postoperative postvoid residual of urine that is within the normal range (less than 100â¯mls) could predict the outcome of TVTO (Tension -free vaginal tape obturator) procedure. STUDY DESIGN: Second Department of Obstetrics and Gynecology, Aretaieio Hospital, University of Athens, Greece. Patients that had been submitted to TVTO procedure between 2013 and 2017 were reviewed and outcome was assessed.The follow up assessment included cough stress test, the Patient Satisfaction Questionnaire (PSQ), the Urinary Distress Inventory-6 (UDI-6) and the Patient Global Impression of Improvement (PGI-I) questionnaire. RESULTS: The mean follow-up was 3.7â¯years (+1.35 years). Forty eight patients (40.3%) had only a TVTO procedure. Forty three patients (36.1%) had a TVTO procedure combined with anterior colporrhaphy. Twenty eight patients (23.6%) underwent a TVTO procedure and anterior colporrhaphy and posterior colpoperineorrhaphy. According to cough stress test 88% patients (105/119) were cured having a negative cough stress test. Using logistic regression analysis it was found that patient's age (pâ¯=â¯0.78), postoperative postvoid residual of urine (â¯=â¯0.24) or day of catheter removal (pâ¯=â¯0.22) had no statistically significant correlation with the medium term outcome of TVTO procedure. Also, regression analysis shows that patients' Body Mass Index (BMI) has negative correlation to the postoperative outcome. CONCLUSION(S): PVRâ¯<â¯50 mls appears to be related with successful medium term outcome after TVTO procedure. Also, patients' (BMI) has negative correlation to the postoperative outcome.
Subject(s)
Quality of Life , Suburethral Slings , Urinary Incontinence/surgery , Urodynamics , Aged , Female , Follow-Up Studies , Humans , Middle Aged , Postoperative Period , Surveys and Questionnaires , Treatment OutcomeABSTRACT
BACKGROUND: The co-chaperone protein Bcl-2-associated athanogene-1 (BAG-1) is overexpressed in breast cancer and has been incorporated in the oncotype DX and PAM50 breast cancer prognostic assays. Bcl-2-associated athanogene-1 exists as multiple protein isoforms that interact with diverse partners, including chaperones Hsc70/Hsp70, Ser/Thr kinase Raf-1 and Bcl-2, to promote cancer cell survival. The BAG-1L isoform specifically binds to and increases the transcriptional activity of oestrogen receptor in cells, and in some, but not all studies, BAG-1 expression is predictive of clinical outcome in breast cancer. METHODS: A systematic review of published studies reporting BAG-1 (mRNA and/or protein) expression and clinical outcome in early breast cancer. The REporting Recommendations for Tumour MARKer and Prognostic Studies (REMARK) criteria were used as a template against which data were assessed. Meta-analyses were performed for studies that provided a hazard ratio and 95% confidence intervals for clinical outcomes including disease-free survival or breast cancer-specific survival from univariate analysis. RESULTS: Eighteen studies used differing methodologies and reported on differing outcomes. Meta-analyses were only possible on results from a subset of reported studies. Meta-analyses suggested improved outcome with high BAG-1 mRNA and high BAG-1 nuclear expression by immunohistochemisty. CONCLUSIONS: Increased levels of BAG-1 are associated with better breast cancer outcomes.
Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/chemistry , Breast Neoplasms/genetics , DNA-Binding Proteins/analysis , DNA-Binding Proteins/genetics , RNA, Messenger/analysis , Transcription Factors/analysis , Transcription Factors/genetics , Biomarkers, Tumor/analysis , Disease-Free Survival , Female , Humans , Survival RateABSTRACT
BACKGROUND: The inherited dysfibrinogenemias comprise rare congenital coagulation disorders which are clinically characterized by bleeding diathesis and, in occasional patients, by thrombotic tendency or combined bleeding-thrombotic events. In recent years, accumulating evidence suggested that fibrinogen has a critical role in the pathogenesis of neuroinflammatory disorders, including multiple sclerosis. We describe the presentation and long-term follow-up of a patient with inherited dysfibrinogenemia and concomitant clinical and laboratory evidence of demyelinating disease. Case description: A 16-year-old male patient presented in 2003 with bilateral sensory symptomatology preceded by an episode of epistaxis. His past medical history included episodes of spontaneous nosebleeds as well as Duane syndrome and mild atrophy of the right upper limb. Coagulation testing of the patient and his asymptomatic father revealed in both the presence of a clotting defect, consistent with inherited dysfibrinogenemia (named Fibrinogen Thessaloniki). Within seven months, the patient presented with a new episode of motor semiology whereas serial brain magnetic resonance imaging (MRI) scans revealed T2 lesions with bilateral distribution, some of which with gadolinium enhancement. The cerebrospinal fluid examination disclosed the presence of oligoclonal bands in the central nervous system compartment. The patient was started on azathioprine (2.5 mg/kg/24h) which led to clinical and radiological stabilization for nine years. In 2013, the dose of azathioprine was reduced, due to an elevation of his amylase levels, resulting in radiological deterioration with an increased T2 lesion load. The reinstitution of azathioprine at therapeutic doses led to radiological improvement and clinical stability as of today. CONCLUSION: The described case of inherited dysfibrinogenemia and concomitant multiple sclerosis provides speculative evidence for a causal link, rather than a chance association, between these two entities. Further studies are warranted to corroborate this hypothesis in experimental and clinical settings. HIPPOKRATIA 2017, 21(1): 49-51.
ABSTRACT
STUDY QUESTION: What are the most relevant factors associated with non-alcoholic fatty liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Insulin resistance (IR) and lipid accumulation product (LAP) are independently associated with NAFLD in PCOS. WHAT IS KNOWN ALREADY: Obesity and IR are frequently present in both women with PCOS and subjects having NAFLD. The coexistence of PCOS and NAFLD might synergistically increase the risk for both type 2 diabetes (T2DM) and cardiovascular disease (CVD). LAP, calculated from waist circumference (WC) and triglycerides (TGs) concentrations [(WC-58) × TGs], has been shown to represent an integrated marker of cardiometabolic risk in women with PCOS. STUDY DESIGN, SIZE, DURATION: This cross-sectional study included 600 Caucasian women diagnosed with PCOS by the Rotterdam criteria between May 2008 and May 2013. PARTICIPANTS, SETTINGS, METHODS: The study was done at the university hospitals in Belgrade, Serbia and Thessaloniki, Greece. All subjects underwent anthropometric measurements and analyses of fasting blood glucose, insulin, lipids, total testosterone and SHBG, as well as liver tests (transaminases, γ-glutamyltransaminase, total bilirubin and alkaline phosphatase). Calculations for a NAFLD liver fat score (NAFLD-LFS) (with, accordingly, determination of metabolic syndrome and testing for T2DM) as well as homeostasis model assessment of IR (HOMA-IR), LAP as a marker of visceral adiposity, and free androgen index (FAI) were performed. We evaluated the prevance of NAFLD and analyzed associations of the above variables with NAFLD. MAIN RESULTS AND THE ROLE OF CHANCE: NAFLD was more prevalent in patients with PCOS than in controls (50.6 versus 34.0%, respectively). Women with PCOS had higher readings for WC, LAP, insulin and HOMA-IR, total cholesterol and TGs than controls (P < 0.001). In PCOS women, the NAFLD-LFS significantly (P < 0.001) correlated with WC, BMI, glucose, HOMA-IR, TGs, LAP and FAI. In multivariate logistic regression, HOMA-IR and LAP were independently associated with NAFLD (P ≤ 0.001). LIMITATIONS, REASONS FOR CAUTION: A possible weakness of the study may be the absence of structural confirmation of liver status. Hovewer, liver biopsy is invasive, difficult to perform in large populations and carries some risk of complications while magnetic resonance spectroscopy does not provide any information regarding the presence of fibrosis and is not routinely available. Another possible limitation could be the measurement of total testosterone by radioimmunoassay, which can be inaccurate when determining low levels of testosterone. Finally, fewer controls than subjects in the study group could have affected the significance of the results. WIDER IMPLICATIONS OF THE FINDINGS: There is a debate on the most accurate clinical method for diagnosing liver disease as an early predictor of T2DM and CVD in general population and in PCOS women. There current study provided data on this issue from a cohort of Caucasian women with PCOS. STUDY FUNDING/COMPETING INTERESTS: The study was supported by a research grant by the Serbian Ministry of Science and Education (grant nos 41009 and 175032). All authors have no competing interests.
Subject(s)
Insulin Resistance , Non-alcoholic Fatty Liver Disease/metabolism , Polycystic Ovary Syndrome/complications , Blood Glucose , Cross-Sectional Studies , Female , Humans , Insulin/blood , Lipids/blood , Liver Function Tests , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/epidemiology , Polycystic Ovary Syndrome/metabolism , Prevalence , Risk Factors , Sex Hormone-Binding Globulin/metabolism , Testosterone/blood , Triglycerides/blood , Waist Circumference , White PeopleABSTRACT
Mammary MCF-10A cells seeded on reconstituted basement membrane form spherical structures with a hollow central lumen, termed acini, which are a physiologically relevant model of mammary morphogenesis. Bcl-2-associated athanogene 1 (Bag-1) is a multifunctional protein overexpressed in breast cancer and ductal carcinoma in situ. When present in the nucleus Bag-1 is predictive of clinical outcome in breast cancer. Bag-1 exists as three main isoforms, which are produced by alternative translation initiation from a single mRNA. The long isoform of Bag-1, Bag-1L, contains a nuclear localisation sequence not present in the other isoforms. When present in the nucleus Bag-1L, but not the other Bag-1 isoforms, can interact with and modulate the activities of estrogen-, androgen- and vitamin D-receptors. Overexpression of Bag-1 mRNA in MCF-10A is known to produce acini with luminal filling reminiscent of ductal carcinoma in situ. As this mRNA predominantly overexpresses the short isoform of Bag-1, Bag-1S, we set out to examine whether the nuclear Bag-1L isoform is sufficient to drive premalignant change by developing a Bag-1L-overexpressing MCF-10A model. Two clones differentially overexpressing Bag-1L were grown in two-dimensional (2D) and three-dimensional (3D) cultures and compared with an established model of HER2-driven transformation. In 2D cultures, Bag-1L overexpression reduced proliferation but did not affect growth factor responsiveness or clonogenicity. Acini formed by Bag-1L-overexpressing cells exhibited reduced luminal clearing when compared with controls. An abnormal branching morphology was also observed which correlated with the level of Bag-1L overexpression, suggesting further malignant change. Treatment with Thio-2, a small-molecule inhibitor of Bag-1, reduced the level of branching. In summary, 3D cultures of MCF-10A mammary epithelial cells overexpressing Bag-1L demonstrate a premalignant phenotype with features of ductal carcinoma in situ. Using this model to test the small-molecule Bag-1 inhibitor, Thio-2, reveals its potential to reverse the atypical branched morphology of acini that characterizes this premalignant change.
ABSTRACT
Axl is a receptor tyrosine kinase (RTK) upregulated in various tumors including cutaneous squamous cell carcinoma (SCC). Axl expression correlates with poor prognosis and induction of epithelial-mesenchymal transition (EMT), hence we hypothesized that Axl is involved in the disruption of cell-cell adhesion to allow invasion and chemotherapy resistance of the cancer stem cell population. Cutaneous SCC cell lines with stable knockdown of Axl were generated using retroviral vectors. Axl depletion altered expression of intercellular junction molecules increasing cell-cell adhesion with downregulation of Wnt and TGFßR signaling. Furthermore, Axl expression correlated with the expression of putative cancer stem cell markers, CD44 and ALDH1, increased resistance to chemotherapy drugs, enhanced sphere formation ability and expression of EMT features by cancer stem cells. Axl depletion resulted in loss of tumor formation in an in vivo zebrafish xenograft model. In conclusion, these data suggest that abrogation of Axl results in loss of cancer stem cell properties indicating a role for Axl as a therapeutic target in chemotherapy-resistant cancer.
Subject(s)
Carcinoma, Squamous Cell/metabolism , Gene Expression Regulation, Neoplastic , Neoplastic Stem Cells/cytology , Proto-Oncogene Proteins/physiology , Receptor Protein-Tyrosine Kinases/physiology , Skin Neoplasms/metabolism , Aldehyde Dehydrogenase 1 Family , Animals , Cell Adhesion , Cell Line, Tumor , Cell Survival , Epithelial-Mesenchymal Transition , Humans , Hyaluronan Receptors/metabolism , Isoenzymes/metabolism , Mice , Neoplasm Transplantation , Receptors, Transforming Growth Factor beta/metabolism , Retinal Dehydrogenase/metabolism , Signal Transduction , Wnt Proteins/metabolism , Zebrafish , Axl Receptor Tyrosine KinaseABSTRACT
PURPOSE OF INVESTIGATION: The present study presents a case with an umbilical cord knot along with extensive literature review. MATERIALS AND METHODS: Presentation of a rare case of second-trimester abortion which was attributed to a tight umbilical cord knot. Furthermore the authors reviewed the literature from 1952 to 2012 in order to compare impact of knots on intrapartum and perinatal outcomes. RESULTS: Four large retrospective studies assessed several predisposing factors. Long umbilical cords, male embryos, and multiparity were correlated with knots in three of these studies. Data regarding perinatal effects of true knots from three studies were summarized and compared. CONCLUSION: Umbilical cord true knots during the second trimester could be a very rare cause of abortion. The presence of knots during the third trimester and labor do not seem to be associated with increased perinatal and intrapartum morbidity and mortality, although there is still some controversy in the literature on this topic.
Subject(s)
Abortion, Spontaneous/etiology , Pregnancy Complications/pathology , Umbilical Cord/pathology , Adult , Female , Humans , Pregnancy , Pregnancy Complications/epidemiology , Pregnancy Trimester, Second , Risk FactorsABSTRACT
AIM: The objective is to present a rare case of late diagnosis of Cornelia de Lange syndrome. CASE: A 27-year-old pregnant woman (gravida 1, para 0) was referred to our Fetal Medicine Department during her 33rd week of gestation due to intrauterine growth restriction (IUGR) and polyhydramnios. The ultrasound scanning confirmed the findings and furthermore, the 3-D examination revealed minor facial dysmorphisms, limb abnormalities, and hypertrichosis. The fetus died 1 week post-diagnosis due to unknown reason and the woman underwent an induction of labor. Postmortem examination confirmed the diagnosis of Cornelia de Lange syndrome. CONCLUSION: The prognosis of the syndrome is severe. Termination of pregnancy before viability is proposed. Genetic counseling is necessary.
Subject(s)
De Lange Syndrome/diagnostic imaging , Fetal Death , Limb Deformities, Congenital/diagnostic imaging , Pregnancy Trimester, Third , Abortion, Induced , Adult , De Lange Syndrome/genetics , Face/abnormalities , Female , Fetal Growth Retardation/diagnostic imaging , Genetic Counseling , Humans , Hypertrichosis/diagnosis , Hypertrichosis/genetics , Limb Deformities, Congenital/genetics , Polyhydramnios/diagnostic imaging , Pregnancy , Ultrasonography, PrenatalABSTRACT
The administration of antibiotics by the inhaled route is a widely recognized treatment in patients with cystic fibrosis (CF) and bronchiectasis. Tobramycin solution for inhalation (TOBI) has been available for many years and is licensed in the USA and Europe. While strong data support the use of aerosolized antibiotics for the treatment of respiratory infections in patients with CF or bronchiectasis, only a few clinical studies have examined the role of aerosolized antibiotics in the treatment of pneumonia, including ventilator-associated pneumonia (VAP) in these patients. During the last decade increasing interest has been directed towards alternative treatments to the systemic administration of antimicrobial agents for the treatment of patients with hospital-acquired pneumonia or VAP due to multidrug-resistant (MDR) Gram-negative bacteria. Recent publications demonstrate the clinical benefits from administering inhaled aminoglycosides or polymyxins in patients with hospital-acquired pneumonia or VAP. In addition to antibiotics, antifungals, and antivirals have been administered by inhalation to specific groups of critically ill patients. However, randomized controlled trials dealing with the administration of anti-infective agents via the respiratory tract are necessary in order to validate the efficacy, safety, advantages, and disadvantages of this therapeutic approach for the treatment of nosocomial pneumonia.
Subject(s)
Aerosols/administration & dosage , Anti-Bacterial Agents/administration & dosage , Colistin/administration & dosage , Administration, Inhalation , Cross Infection/drug therapy , Humans , Pneumonia, Bacterial/drug therapy , Pneumonia, Ventilator-Associated/drug therapy , Randomized Controlled Trials as TopicSubject(s)
Breast Neoplasms/complications , Diabetes Complications/drug therapy , Diabetes Mellitus/drug therapy , Emphysema/complications , Kidney Calculi/complications , Lymphopenia/chemically induced , Pyelonephritis/complications , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Diabetes Complications/pathology , Diabetes Mellitus/pathology , Docetaxel , Emphysema/drug therapy , Emphysema/pathology , Epirubicin/administration & dosage , Female , Humans , Kidney Calculi/drug therapy , Kidney Calculi/pathology , Lymphopenia/prevention & control , Middle Aged , Pyelonephritis/drug therapy , Pyelonephritis/pathology , Taxoids/administration & dosage , Treatment OutcomeABSTRACT
Increasing the level and duration of transgene expression and restricting expression to vascular cells are important goals for clinically useful gene therapy vectors. We evaluated several promoters, enhancers and introns in endothelial, smooth muscle and liver cells in tissue culture and in vivo, comparing local delivery to the carotid artery with intravenous delivery to the liver. A 1800-bp fragment of the oxidized LDL receptor (LOX-1) promoter showed highest in vivo activity in the carotid artery, achieving 39% the activity of the reference cytomegalovirus promoter, with 188-fold greater specificity for carotid artery over liver. An enhancer from the Tie2 gene in combination with the intracellular adhesion molecule-2 promoter improved endothelial specificity of plasmid vectors, increased the expression from adenoviral vectors in cultured endothelial cells and doubled the specificity for carotid artery over liver in vivo. Adding a short intron to expression cassettes increased expression in both endothelial and smooth muscle cells in vitro; however, the eNOS enhancer failed to consistently increase the expression or endothelial specificity of the vector. In conclusion, elements from the LOX-1 promoter and Tie2 enhancer together with an intron can be used to improve vectors for vascular gene transfer.
Subject(s)
Genetic Therapy/methods , Genetic Vectors/genetics , Muscle, Smooth, Vascular/metabolism , Vascular Diseases/therapy , Adenoviridae/genetics , Chi-Square Distribution , Endothelial Cells/metabolism , Enhancer Elements, Genetic , Gene Expression , Genetic Engineering , Humans , Introns , Linear Models , Liver/metabolism , Luciferases/genetics , Promoter Regions, Genetic , Receptor, TIE-2/genetics , Scavenger Receptors, Class E/genetics , Transduction, Genetic/methodsABSTRACT
Aim of the study was to estimate the incidence of coronary heart disease (CAD) in patients (pts) with end stage renal disease (ESRD) maintained on chronic hemodialysis (HD) and its association with the presence of predisposing factors. The study included 171 dialysis pts (107 male (M) and 64 female (F)). Mean age of pts was 67+/-13 years, mean time on dialysis 52.7+/-44 months and Body Mass Index (BMI) 25.9+/-3.7 kg/m2. Fifty pts (29.2%) were clinically diagnosed with CAD. The diagnosis was established by coronary angiography in 24 (48%) and in 26 by combined dipyridamole-exercise thallium imaging (52%). Pts' data in association with the development of CAD that were recorded included age, sex, smoking habits, hypertension, obesity, the presence of diabetes mellitus (DM), hyperlipidemia, anemia, low albumin levels, secondary hyperparathyroidism (SHP), the presence of chronic inflammation, as evidenced by the presence of elevated levels of CRP and hyperhomocysteinemia. There was a statistically significant association of increasing age and CAD (p<0.0001). Relative risk (RR) was significantly increased i) in male pts compared to female pts (RR: 8.56, p<0.001), ii) in anemic pts compared to pts with hemoglobin levels< or =11 g/dL (RR: 8.26, p<0.0001), iii) in obese pts compared to pts with BMI < or =30 (RR: 5.09, p<0.005) and iv) in pts with increased levels of homocysteine compared to pts with levels of homocysteine <15 |IM (RR: 4.14, p<0.0001). Using linear regression analysis, CAD was associated with the inadequacy of HD (r = - 0.05, p<0.0001), time on HD (r =0.04, p =0.012) and increasing age (r =0.24, p<0.001). There was no statistically significant association between CAD and the presence of the other traditional risk factors. The incidence of CAD in dialysis pts is significantly increased with age, male sex, obesity, time on dialysis, the presence of anemia, hyperhomocysteinemia and inadequacy of HD.
Subject(s)
Coronary Artery Disease/epidemiology , Kidney Failure, Chronic/therapy , Renal Dialysis , Aged , Aged, 80 and over , Female , Follow-Up Studies , Greece , Humans , Incidence , Kidney Failure, Chronic/complications , Male , Middle Aged , Retrospective Studies , Risk Factors , Severity of Illness IndexABSTRACT
OBJECTIVES: To compare the psychophysical properties of the new Kodak InSight F-speed intraoral dental film with those for the E-speed Ektaspeed Plus film by means of the perceptibility curve (PC) test. METHODS: A specially designed test object was used. The test object was made of aluminium and was 10 mm thick. It contained ten holes, contrast details, with the same diameter of 1.5 mm but with different depths. The depths ranged from 0.03 mm to 0.30 mm in steps of 0.03 mm. The holes were placed randomly within a square area with a total of 16 possible positions. Radiographs of the test object were obtained over the full exposure ranges of the two films. A Combex DX-907 dental X-ray unit was used operating at 10 mA and two tube potentials, 70 kVp and 90 kVp. The focus-to-object distance was 50 cm. Ten observers evaluated the radiographs under uniform artificial lighting using a view box and stated the number of perceptible representations of contrast details. In order to construct perceptibility curves, absolute values of the reciprocal of the minimum perceptible logarithmic exposure differences, 1/(DeltalogE)min, were plotted as functions of the logarithm of exposures, logE, registered by the tested films. Comparisons between the two films were made separately for the two tube potentials, 70 kVp and 90 kVp. RESULTS: The results are presented graphically. PCs for the InSight film had higher peaks than those for the Ektaspeed Plus film. This indicates that the viewers were able to perceive smaller exposure differences in the former compared with the latter. PCs for the InSight film were shifted towards the left along the exposure axis relative to the PCs for the Ektaspeed Plus film indicating that the former film is more sensitive than the latter. The integrals of the PCs for InSight film were larger than those for Ektaspeed film indicating superior psychophysical properties of the InSight film. CONCLUSIONS: From the point of view of perception, the new InSight film has such psychophysical properties in comparison with Ektaspeed Plus film that it will be the more favourable of the two in clinical radiographic practice.
Subject(s)
Radiography, Dental/instrumentation , X-Ray Film , Absorptiometry, Photon , Algorithms , Aluminum , Humans , Light , Linear Models , Observer Variation , Psychophysics , Radiographic Image Enhancement , Surface Properties , Visual Perception/physiology , X-Ray Film/classificationABSTRACT
It has become apparent that the clinical success anticipated in the field of gene therapy has been limited by progress in several of the fundamental areas of genetics, molecular and cellular biology relevant to its application. Whilst a great deal of effort has been made in the evaluation of transgenes, it is only more recently with the advance of vector systems that attention has begun to be focused upon the means and control of transgene expression. Until recently, the majority of constructs have employed ubiquitous viral promoters to drive expression from simple gene expression cassettes using viral promoters and lacking introns, 3' untranslated regions (UTRs), locus control regions (LCR's), matrix attachment regions (MAR's) and other such genetic components. It has consequently emerged that these elements may have a key role in determining the levels and longevity of gene expression attainable in vivo, irrespective of the vector system utilised. The majority of gene therapy applications would also benefit from the specific optimisation of 'tailor-made' expression cassettes to optimise their therapeutic efficacy. In conjunction with modification of vector tropism and strategies to limit their immunogenicity, this should create vectors suitable for the clinical application of gene therapy. This review aims to highlight some of the principle considerations of gene expression in vivo, and the means by which it may most effectively be achieved, whether this is via the minimal modification of an existing eukaryotic promoter or by the more extensive design of a novel promoter and associated elements.
Subject(s)
Gene Expression Regulation , Genetic Therapy/methods , Genetic Vectors/chemistry , Promoter Regions, Genetic , Regulatory Sequences, Nucleic Acid , Animals , Eukaryotic Cells/metabolism , Genetic Vectors/genetics , Humans , Neoplasms/therapy , Transcription Factors/metabolism , Viruses/geneticsABSTRACT
H-ras is a member of the ras superfamily of genes. This gene encodes for a 21 kDa protein (p21) which is located on the inner surface of the plasma membrane. Ras genes are involved in a wide variety of human tumors, and there is a known correlation between H-ras activation and breast carcinogenesis. H-ras contains a polymorphic region, a repeated hexanucleotide -GGGCCT - located in intron 1 close to the 5' of the gene (HRM region). Three alleles of this region, P1, P2 and P3, have been identified that contain two, three and four repeats of the hexanucleotide, respectively. H-ras possesses a minisatellite DNA of the variable tandem repeat (VTR) which is located 1000 bp downstream of the gene displaying linkage disequilibrium with HRM. The purpose of this study was to estimate the frequency of P1, P2 and P3 in the normal population and in patients with breast cancer. We studied 56 biopsy specimens from patients with breast cancer, 61 normal blood samples, and 30 pairs of normal and tumoral breast tissues for VTR analysis. There was a difference in the distribution of P1, P2 and P3 alleles between normal and breast cancer samples. The frequency of P1 homozygosity was shown to be almost twice as high in women with breast cancer compared to healthy women (72% versus 39%). These results suggest that P1 homozygosity may be considered as a potential risk factor in breast carcinogenesis. In VTR analysis one sample presented a shift in mobility, but no polymorphism in the BstN I pattern of the 28 bp repetition core was observed.